<DOC>
	<DOCNO>NCT00541463</DOCNO>
	<brief_summary>A study compare Indinavir plus Ritonavir plus 2 NRTIs vs. Nelfinavir 1250 plus two nucleoside reverse transcriptase inhibitor ( NRTIs ) treatment HIV positive patient respond intolerant non-nucleoside reverse transcriptase inhibitor ( NNRTI ) contain treatment .</brief_summary>
	<brief_title>A Study Indinavir Plus Ritonavir Plus Two NRTIs vs. Nelfinavir Plus Two NRTIs HIV Positive Patients ( 0639-112 ) ( COMPLETED )</brief_title>
	<detailed_description />
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Ritonavir</mesh_term>
	<mesh_term>Nelfinavir</mesh_term>
	<mesh_term>Indinavir</mesh_term>
	<criteria>At least 18 year age HIV positive No active heart disease Pregnant breast feed Unwilling use birth control abstinence prevent pregnancy Received investigational drug vaccine within past 30 day plan receive investigational study drug/vaccine interferon study Plan receive NNRTIs study Received therapy lower body 's ability fight infection within past 30 day study Alcohol substance abuse Hepatitis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>HIV</keyword>
	<keyword>Treatment Experienced</keyword>
</DOC>